| human | Q5 |
| P856 | official website | https://www.ndcn.ox.ac.uk/team/george-tofaris |
| P496 | ORCID iD | 0000-0002-9252-5933 |
| P69 | educated at | University of Cambridge | Q35794 |
| P108 | employer | University of Oxford | Q34433 |
| P735 | given name | George | Q15921732 |
| George | Q15921732 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q47157967 | A Critical Assessment of Exosomes in the Pathogenesis and Stratification of Parkinson's Disease. |
| Q42508245 | Adult-onset neurodegeneration with brain iron accumulation and cortical alpha-synuclein and tau pathology: a distinct clinicopathological entity. |
| Q82605532 | An unusual cause of rigors and microscopic haematuria |
| Q48246370 | Concentration-Normalized Electroanalytical Assaying of Exosomal Markers. |
| Q49832958 | Convergent molecular defects underpin diverse neurodegenerative diseases |
| Q40713981 | Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. |
| Q37181996 | Deubiquitinase Usp8 regulates α-synuclein clearance and modifies its toxicity in Lewy body disease. |
| Q35943026 | Dopamine enhances willingness to exert effort for reward in Parkinson's disease. |
| Q36678823 | ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons. |
| Q42740346 | Endogenous alpha-synuclein influences the number of dopaminergic neurons in mouse substantia nigra |
| Q37706391 | Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease. |
| Q80509801 | Focal Paraneoplastic Syndrome associated with small cell carcinoma of the lung |
| Q39760969 | Identification of distinct circulating exosomes in Parkinson's disease |
| Q30519510 | Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis |
| Q35932798 | Intact Acquisition and Short-Term Retention of Non-Motor Procedural Learning in Parkinson's Disease |
| Q38038561 | Lysosome-dependent pathways as a unifying theme in Parkinson's disease. |
| Q57498821 | Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) in the older adult |
| Q91639682 | Monitoring α-Synuclein Proteotoxicity in Drosophila Models |
| Q86885145 | Neurodegenerative diseases in the era of targeted therapeutics: how to handle a tangled issue |
| Q48586171 | Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders. |
| Q112305944 | Phenotypic manifestation of α-synuclein strains derived from Parkinson's disease and multiple system atrophy in human dopaminergic neurons |
| Q27303483 | Reward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson’s disease |
| Q33944220 | SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease |
| Q91785721 | Serum neuronal exosomes predict and differentiate Parkinson's disease from atypical parkinsonism |
| Q51731758 | Stem Cell modeling of Mitochondrial Parkinsonism reveals key functions of OPA1. |
| Q51284194 | The Transcellular Propagation and Intracellular Trafficking of α-Synuclein. |
| Q80816640 | The effect of truncated human alpha-synuclein (1-120) on dopaminergic cells in a transgenic mouse model of Parkinson's disease |
| Q38363403 | The endosomal pathway in Parkinson's disease. |
| Q35344983 | Ubiquitin ligase Nedd4 promotes alpha-synuclein degradation by the endosomal-lysosomal pathway |
Search more.